DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced Michael J. Rybak, PharmD, MPH, FCCP, FIDSA, has joined its scientific advisory board.
DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced Michael J. Rybak, PharmD, MPH, FCCP, FIDSA, has joined its scientific advisory board.
